Licensed books on medicine
<< Previous || Next >> |
CHRONIC PULMONARY HEART
Chronic pulmonary heart refers to hypertrophy of the right ventricle against a background of a disease that affects the function or structure of the lungs, or both at the same time, except when these pulmonary changes are the result of damage to the left heart or congenital heart defects.
It is often associated with chronic bronchitis, emphysema, bronchial asthma, pulmonary fibrosis and granulomatosis, tuberculosis, silicosis, with conditions that violate the mobility of the chest - kyphoscoliosis, ossification of the costal joints, obesity.
The disease primarily affects the pulmonary vessels: thrombosis and pulmonary embolism, endarteritis.
Mortality from chronic pulmonary heart disease came in 4th place. In the early stages, it is clinically poorly diagnosed. In 70 - 80% of cases, the cause is chronic bronchitis, especially destructive.
| << Previous || Next >> |
| = Skip to textbook content = |
CHRONIC PULMONARY HEART
- 52. LUNG HEART. ETHIOLOGY, PATHOGENESIS OF ACUTE AND SUBCUTANEOUS, CHRONIC PULMONARY HEART, CLINIC, DIAGNOSTIC, TREATMENT PRINCIPLES.
Pulmonary sero-pathological condition characterized by hypertrophy of the right ventricle caused by hypertension of the pulmonary circulation, which develops with damage to the bronchopulmonary apparatus, pulmonary vessels, chest deformity, or other diseases that impair lung function. Acute heart lay-wedge symptom complex arising from pulmonary artery thromboembolism, and with
- Heart diseases. Coronary heart disease (CHD). Reperfusion syndrome. Hypertensive heart disease. Acute and chronic pulmonary heart.
1. IHD is 1. productive myocarditis 2. myocardial fatty degeneration 3. right ventricular failure 4. absolute coronary circulatory failure 5. relative coronary insufficiency 2. Forms of acute coronary heart disease 1. myocardial infarction 2. cardiomyopathy 3. angina pectoris 4. exudative myocarditis 5 sudden coronary death 3. With angina pectoris in cardiomyocytes
- HEART DISEASES. CORONARY HEART DISEASE. HYPERTENSIVE HEART DISEASE. Myocardial hypertrophy. ACUTE AND CHRONIC PULMONARY HEART
HEART DISEASES. CORONARY HEART DISEASE. HYPERTENSIVE HEART DISEASE. Myocardial hypertrophy. ACUTE AND CHRONIC PULMONARY
- CHRONICAL BRONCHITIS. CHRONIC PULMONARY HEART.
In recent years, due to the deteriorating environmental situation, the prevalence of smoking, and a change in the reactivity of the human body, there has been a significant increase in the incidence of chronic non-specific lung diseases (COPD). The term KNZL was adopted in 1958 in London at a symposium convened by the pharmaceutical group Ciba. He combined such diffuse diseases
- 1.4. CHRONIC PULMONARY HEART (HLC)
The treatment of patients with chronic heart disease should be comprehensive and aimed at reducing pressure in the pulmonary artery (LA), improving bronchial patency and alveolar ventilation, eliminating pulmonary and heart failure, which can be achieved with adequate therapy for the underlying disease that led to the onset of chronic heart disease. 1. Bronchodilators - selective short-acting beta2-adrenostimulants
- Pulmonary heart and pulmonary circulation disorders
ICD code: (126-128) 126 Pulmonary embolism 126.0 Pulmonary embolism with reference to acute pulmonary heart 126.9 Pulmonary embolism without mention of acute pulmonary heart 127 Other forms of pulmonary heart failure 127.0 Primary pulmonary hypertension 127.1 Kyphoscoliotic heart disease 127.8 Other specified forms of pulmonary heart failure 127.9
- Pulmonary heart
PULMONARY HEART (LS) is a clinical syndrome caused by hypertrophy and / or dilatation of the right ventricle resulting from hypertension in the pulmonary circulation, which in turn develops as a result of diseases of the bronchi and lungs, chest deformity, or damage to the pulmonary vessels. Classification. B.E. Votchal (1964) proposes to classify the pulmonary heart by 4
- PULMONARY HEART
Alfred P. Fishman (Alfred P. Fishman) Under the pulmonary heart understand the increase in the right ventricle due to impaired lung function. However, impaired lung function does not always occur due to a disease of the lungs proper: in some cases, the cause is chest deformity or inhibition of the respiratory impulse from the respiratory center (Table 191-1). In those
- PULMONARY HEART
Pulmonary heart is understood as a clinical syndrome caused by hypertrophy and (or) dilatation of the right ventricle resulting from hypertension in the pulmonary circulation, which in turn develops as a result of bronchial and pulmonary disease, chest deformity, or pulmonary vascular disease. The main clinical manifestations of the patient's complaints are determined by the main
- Clinical protocol for providing medical care to patients with chronic rheumatic heart disease (heart defects)
ICD-10 heading: U5-GO9 Conditions under which medical care should be provided All patients with heart defects should be referred for surgical treatment to the appropriate specialized institutions. In cases of impossibility or delay of surgical treatment, such patients are subject to outpatient examination and treatment at the place of residence. The survey may be conducted in district
- Pulmonary heart
Signs and symptoms of pulmonary heart • Dyspnea. • ???? When straining - loss of consciousness. • ???? Accent II tone over the pulmonary artery. • ???? The appearance of wave A on the pressure curve of the right atrium during its invasive registration. • ???? The presence of signs of left ventricular failure. 126.96.36.199. Preoperative preparation in patients with pulmonary heart • ???? Elimination of pulmonary infection
- Pulmonary (right ventricular) hypertensive heart disease
(pulmonary heart, cor pulmonale) can be acute and chronic. Acute pulmonary heart develops with massive thromboembolism into the pulmonary artery system and is manifested by acute dilatation of the right ventricle (and then the right atrium) and acute right ventricular failure. Chronic pulmonary heart is distinguished by working concentric hypertrophy of the right ventricle (reaching thickness
- Chronic obstructive pulmonary disease in children
Protocol code: 04-044в Profile: pediatric Stage: hospital Purpose of stage: 1. Establishment of a final diagnosis and development of treatment tactics; 2. elimination of inflammatory manifestations in the lungs; 3. elimination of symptoms of bronchial obstruction, symptoms of intoxication and correction of metabolic disorders; 4. improving the quality of life. Duration of treatment: 21 days ICD codes: J44.0 Chronic
- Asthma and chronic obstructive pulmonary disease (HOLS)
Pathophysiology. Asthma is called acute generalized obstruction of the respiratory tract, accompanied by bronchospasm due to their hyperreactivity and the release of inflammatory mediators (for example, histamine). Chronic obstructive pulmonary disease (COPD) is defined as airway obstruction caused by various structural and functional factors, such as hypertrophy